Purpose: The aims of the present prospective study were to apply a new simplification for Laparoscopic Burch Colposuspension and to
assess the postoperative results of this treatment modality for stress urinary incontinence.Materials and methods: Twenty-four patients underwent simplified laparoscopic procedure via two ports, utilising endoscopic tacker and two stripes
of prolene mesh. Patients were evaluated for operative time,duration of urethral catheter, length of hospital stay, complications
and continence status.Results: The technique was successful in 21 patients after 24 months follow-up. Average operative time was 39 minutes. The lengths
of urethral catheterisation and hospital stay were 22 and 45 hours, respectively. One operative complication and three postoperative
recurrences were recorded.Conclusion: Laparoscopic bladder neck suspension continues to develop as the instruments and techniques are improved. In carefully evaluated
patients, it provides safe and minimally invasive procedure. We report the results of a new technique to simplify and speed
up a laparoscopic extraperitoneal colposuspension.
This revised version was published online in August 2006 with corrections to the Cover Date. 相似文献
Background and purpose: Amifostine has been shown to protect against xerostomia induced by radiotherapy for head and neck cancer, but its impact on the therapeutic index is unknown. This is the first report focusing on amifostine related adverse effects leading to discontinuation of amifostine treatment.
Patients and methods: Thirty-nine patients from two centers irradiated for head and neck cancer received i.v.-infusions of amifostine prior to each radiation fraction. In a phase III study, two daily amifostine doses, 200 mg/m2 (n=21) and 340 mg/m2 (n=18), were compared for protection against radiation induced toxicity. Total radiation dose was 60–70 Gy (2 Gy per fraction), nine patients received concurrent chemotherapy with cisplatin/5-FU. amifostine was usually discontinued after >1 episode of serious toxicity during subsequent treatment sessions.
Results: In 16/39 patients (41%) amifostine was discontinued due to severe adverse effects, which led to discontinuation of the phase III study. In four of 16 patients radiotherapy was delayed due to amifostine related adverse effects for 1–3 days. Discontinuation occurred more often in patients receiving chemotherapy. The results led to a literature review for amifostine treatment during radiotherapy in head and neck cancer patients. Regarding our series and published series using an amifostine schedule comparable to ours, total discontinuation rate was 27% (57/214). Discontinuation was significantly influenced by chemotherapy (P=0.007), but not by amifostine dose (P=0.156).
Conclusion: Daily i.v. administration of amifostine during radiotherapy in head and neck cancer is associated with a high rate of serious adverse effects leading to discontinuation of amifostine treatment and sometimes delay of radiotherapy. 相似文献
T-lymphocyte cell function was studied in vitro in peripheral blood mononuclear cells (PBMC) from 61 male patients with head
and neck squamous cell carcinomas compared to 46 control patients. Patients older than 80 years or with reduced tumor-related
performance status as measured by Karnofsky score less than 75 were excluded. In contrast to previous similar studies, control
subjects ensured a minimum stress load by sampling all patients on the day of either diagnostic or therapeutic surgery. PBMC
were separated by density-gradient centrifugation and subsequently cultured with autologous sera in vitro. The mitogen concanavalin
A (Con A), which stimulates all T-cell clones, was employed. Findings showed that increased Con A stimulation and PBMC proliferation
occurred with PBMC from cancer patients compared to that from control patients. In contrast, no differences could be detected
with respect to the stimulated supernatant level of interleukin-2, interleukin-4 or interferon-γ between the groups. These
results suggest that T-lymphocytes from PBMC are generally affected by neoplastic disease through either a supporting cell
or serum factor. 相似文献